Leland J Yee

8PUBLICATIONS
35CO-AUTHORS
Liquid biopsiesEpidemiological methodsGene and molecular therapyCardiology (incl. cardiovascular diseases)Haematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Apr 01, 2026
Increased Risk for Liver Disease in Patients With Chronic Hepatitis B Virus Infection and Low-Level Viraemia.

Paul Y Kwo, Laura E Telep, Lai San Hong

|Aug 12, 2025
Efficacy and Safety of Tenofovir Alafenamide (TAF) and Tenofovir Disoproxil Fumarate (TDF) Followed by TAF in Chronic Hepatitis B Patients of East Asian Ethnicity Following 5 Years of Treatment.

Grace Lai-Hung Wong, Edward Gane, Calvin Q Pan

|Sep 27, 2024
Eight-year efficacy and safety of tenofovir alafenamide for treatment of chronic hepatitis B virus infection: Final results from two randomised phase 3 trials.

Maria Buti, Young-Suk Lim, Henry Lik Yuen Chan

|May 08, 2024
Hepatocellular carcinoma among patients with chronic hepatitis B in the indeterminate phase.

Lung-Yi Mak, Leland J Yee, Robert J Wong

|Mar 04, 2024
Chronic hepatitis B baseline viral load and on-treatment liver cancer risk: A multinational cohort study of HBeAg-positive patients.

Won-Mook Choi, Terry Cheuk-Fung Yip, W Ray Kim

|Oct 31, 2023
Atherosclerotic cardiovascular disease risk profile of patients with chronic hepatitis B treated with tenofovir alafenamide or tenofovir disoproxil fumarate for 96 weeks.

Scott K Fung, Calvin Q Pan, Grace Lai-Hung Wong

Pageof 2

Frequent Collaborators

4 joint publications

Young-Suk Lim

3 joint publications

Wai-Kay Seto

3 joint publications

Maria Buti

2 joint publications

Jia-Horng Kao